|
||||||
| Home |
| Find a Clinical Trial |
| Clinical Trial FAQs |
| About Informed Consent |
| Clinical Trials Glossary |
| Medical Research Areas |
| Clinical Trial Resources |
|
 |
Sign up and receive information about Novartis clinical trials in your health-related areas of interest. For U.S. residents only. | |
|
|
 |
|
|
|
|||
|
Novartis Clinical
Trials provides information about research studies recruiting
within the U.S. Visit ClinicalTrials.gov, a registry of federally and privately supported clinical trial for more information regarding clinical trials outside of the U.S. |
|
|
Find a Clinical Trial
Gout
This is an acute form of arthritis that is nearly always associated with a long-lasting, abnormally high concentration of uric acid in the blood, which can lead to the deposition of urate crystals in and around joints (often those involving the big toe), producing pain, swelling, and other signs of inflammation. It mostly affects men age 40 and older.
Novartis is seeking people to participate in a clinical trial(s) testing the safety and effectiveness of Novartis products. Novartis recommends that you consult your doctor before participating in a clinical trial. For more information about clinical trial participation, click here. Also, for additional information about how Novartis helps to protect the privacy of the personal information that you provide to us, please see the Novartis Privacy Policy. Please review the details of the clinical trial(s) listed below and click on the one that you feel best suits your (or the participant's) condition.
Gout Study - H2357
The purpose of this randomized, controlled study is to evaluate the efficacy of a Novartis investigative drug in relieving pain from the acute gout flare and preventing recurrence of new gout flares, in sufferers that are either intolerant or non-responsive to traditional non-steroidal anti-inflammatory drugs (NSAIDs) and/or colchicine treatments.
An investigational drug is a drug that is being tested and is not approved for sale in the United States by the Food and Drug Administration (FDA).
Trial phase: Phase 3 Participation Duration: Participants will be required to visit the study center 7 times over a 3 month period. Three additional visits will be required for each acute gout flare up.. Protocol Number: CACZ885H2357 |